Abstract
Besides the actual testing and analysis of samples, application of follow-up procedures, et cetera, screening programmes also involve the processes of contacting people for recruitment to the programme, informing them about the procedures prior to testing, as well as about the result of the test afterwards, counselling about possible follow up-procedures, and help with coping with the reactions to the test result. These features of screening programmes give rise to a host of questions of how screening programmes should be designed and conducted in these respects. Plausibly, all programmes should involve all of the tasks mentioned to some extent. But how much? And in what way? If ill-designed, the programme may end up not promoting the values it could have promoted and producing negative side-effects it could have avoided. So, even if defensible in terms of the condition targeted, the testing method utilised and the treatments available, a programme may still be open to serious criticism if organised in an inferior way. This has been underscored, e.g., in research on the new risk assessment methods in prenatal screening discussed in Section 3.2.1.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Saltvedt (2005).
- 2.
See e.g. ESHG (2003), p. 56, point (12) and (23).
- 3.
Hoedemaekers (1999), p. 216.
- 4.
Munthe (1996).
- 5.
- 6.
Parens and Asch (2000).
- 7.
Munthe et al. (1998).
- 8.
- 9.
- 10.
- 11.
ESHG (2003), p. 56, point (27).
- 12.
Juth (2005), pp. 92–98.
- 13.
See Tännsjö (1999), where a radical ideal of anti-paternalism in health care is defended on the basis of this kind of considerations.
- 14.
Nijsingh (2007).
- 15.
Sandman and Munthe (2009).
- 16.
See Beauchamp and Childress (2001), chapters 3–5. The position that respect for autonomy should only be prima facie and not absolute, regardless of basis, is argued in Juth (2005), pp. 205–206.
- 17.
Fraser (1974), p. 637. Adopted by the American Society of Human Genetics in 1975, this conception of genetic counselling has since then become standard.
- 18.
Holm (1999).
- 19.
- 20.
- 21.
Platt Walker (1998), p. 5.
- 22.
Fraser (1974), p. 637.
- 23.
There are genetic analyses made without molecular or other biochemical testing, most notably by making a pedigree of a family history of disease. For those cases, it is more appropriate to talk about pre- and post-analysis.
- 24.
Platt Walker (1998), p. 9.
- 25.
Platt Walker (1998), p. 10.
- 26.
Sobel and Cowan (2000).
- 27.
For instance, the increased risk of suicide due to a cancer diagnosis (see Section 5.4).
- 28.
Juth (2005), pp. 79–97.
- 29.
Juth (2005), pp. 85–87.
- 30.
- 31.
ten Have (2000).
- 32.
See Juth (2005), p. 87 for a discussion and further references regarding this.
- 33.
Juth (2005), p. 89.
- 34.
Munthe (1999), p. 85.
- 35.
This is also increasingly recognized in the discussion about genetic counselling . See Shiloh (1996).
- 36.
Kessler (1997), pp. 169–170.
- 37.
- 38.
Sandman and Munthe (2010).
- 39.
Sandman and Munthe (2009).
- 40.
Cf. Danish Council of Ethics (1999), chapter 5.3.
- 41.
E.g. Justman (2010) claims that harms should be weighed considerably higher in preventive medicine (see Section 5.3).
- 42.
For instance mammography programs (see Section 5.3).
References
Beauchamp, T.L., and J.F. Childress. 2001. Principles of biomedical ethics, 5th edition. New York, NY and Oxford: Oxford University Press.
Danish Council of Ethics. 1999. Screening – A report. Copenhagen: The Danish Council of Ethics.
ESHG (European Society of Human Genetics). 2003. Population genetic screening programmes: Technical, social and ethical issues. Recommendations of the European Society of Human Genetics. European Journal of Human Genetics 11:5–7.
Fraser, F.C. 1974. Genetic counseling. American Journal of Human Genetics 26:636–659.
Häyry, M., and T. Takala. 2000. Genetic ignorance, moral obligations and social duties. Journal of Medicine and Philosophy 1:107–113.
Hoedemaekers, R. 1999. Genetic screening and testing. A moral map. In The ethics of genetic screening, eds. R. Chadwick et al. Dordrecht: Kluwer Academic Publishers.
Holm, S. 1999. There is nothing special about genetic information. In Genetic information: Acquisition, access and control, eds. A.R. Thompson and R. Chadwick, 97–103. New York, NY: Kluwer Academics/Plenum Publishers.
Justman, S. 2010. Uninformed consent: Mass screening for prostate cancer. Bioethics, Article first published online: 28 Jun 2010, doi: 10.1111/j.1467-8519.2010.01826.x.
Juth, N. 2005. Genetic information – values and rights: The morality of presymptomatic genetic testing. Göteborg: Acta Universitatis Gothoburgensis.
Kessler, S. 1997. Psychological aspects of genetic counseling. XI. Nondirectiveness revisited. American Journal of Medical Genetics 72:164–171.
Munthe, C. 1996. The moral roots of prenatal diagnosis. Ethical aspects of the early introduction and presentation of prenatal diagnosis in Sweden. Göteborg: Centrum för forskningsetik.
Munthe, C. 1999. Pure selection. The ethics of preimplantation genetic diagnosis and choosing children without abortion. Göteborg: Acta Universitatis Gothoburgensis.
Munthe, C., J. Wahlström, and S. Welin. 1998. Fosterdiagnostikens moraliska rötter. Goda handikappomsorger avgörande för den etiska kvaliteten (The moral roots of prenatal diagnosis. Good disability care crucial for the ethical quality). Läkartidningen (Physician’s Review) 95:750–753.
Nijsingh, N. 2007. Informed consent and the expansion of newborn screening. In Ethics, prevention and public health, eds. A. Dawson and M. Verweij. Oxford: Oxford University Press.
Parens, E., and A. Asch. 2000. Prenatal testing and disability rights. Washington, DC: Georgetown University Press.
Platt Walker, A. 1998. The practice of genetic counselling. In A guide to genetic counselling, ed. D.L. Baker, 1–20. Chichester: Wiley-Liss Inc.
Saltvedt, S. 2005. Prenatal diagnosis in routine antenatal care – A randomised controlled trial. Stockholm: Kongl Carolinska Medico Chirurgiska Institutet.
Sandman, L., and C. Munthe. 2009. Shared decision making and patient autonomy. Theoretical Medicine and Bioethics 30(4):289–310.
Sandman, L., and C. Munthe. 2010. Shared decision making, paternalism and patient choice. Health Care Analysis 18(1):60–84.
Shiloh, S. 1996. Decision-making in the context of genetic risk. In The troubled helix: Social and psychological implications of the new human genetics, eds. T. Marteau and M. Richards, 82–103. Cambridge: Cambridge University Press.
Sobel, S.K., and D.B. Cowan. 2000. Impact of genetic testing for Huntington disease on the family system. American Journal of Medical Genetics 90:49–59.
ten Have, H. 2000. Genetics and culture. In Bioethics in a European perspective, eds. H. ten Have and B. Gordijn. Nijmegen: Programme of the European Masters in Bioethics.
WHO. 1998. Proposed international guidelines on ethical issues in medical genetics and the provision of genetic services. Geneva: WHO 15–16 Dec 1997.
Wilkinson, S. 2003. Bodies for sale. Ethics and exploitation in the human body trade. London: Routledge.
Tännsjö, T. 1999. Coercive care. The ethics of choice in health and medicine. London: Routledge.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Juth, N., Munthe, C. (2012). Screening – How?. In: The Ethics of Screening in Health Care and Medicine. International Library of Ethics, Law, and the New Medicine, vol 51. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-2045-9_4
Download citation
DOI: https://doi.org/10.1007/978-94-007-2045-9_4
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-2044-2
Online ISBN: 978-94-007-2045-9
eBook Packages: MedicineMedicine (R0)